Alkahest is a biopharmaceutical company specializing in plasma therapies. It targets neurodegenerative and age-related diseases with transformative therapies derived from blood. The company focuses on Alzheimer’s and Parkinson’s diseases, age-related macular degeneration (AMD), etc.